Legal & General Group
BBNX

Legal & General Group’s Beta Bionics BBNX Stock Holding History

Legal & General Group’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$60.5K Sell
6,036
-498
-8% -$7.37K ﹤0.01% 2650
2025
Q4 		$199K Sell
6,534
-100
-2% -$2.67K ﹤0.01% 2583
2025
Q3 		$132K Buy
6,634
+2,658
+67% +$46.7K ﹤0.01% 2622
2025
Q2 		$57.9K Buy
3,976
+2,639
+197% +$37.4K ﹤0.01% 2693
2025
Q1 		$16.4K Buy
+1,337
New +$24.9K ﹤0.01% 3018

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Legal & General Group's BBNX Position: Q1 2026 in Review

Legal & General Group reduced its Beta Bionics (BBNX) stake by 7.6% in Q1 2026, selling an estimated $7.37K and leaving 6,036 shares worth $60.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2650.

Legal & General Group first reported a position in BBNX in Q1 2025 and has held it in 5 quarters since. The position peaked at $199K in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Legal & General Group held 6,036 shares of Beta Bionics worth $60.5K as of Q1 2026.
  • Legal & General Group sold 498 Beta Bionics shares in Q1 2026, an estimated $7.37K.
  • Beta Bionics made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2650 holding.
  • Legal & General Group first reported a position in Beta Bionics in Q1 2025 and has held it in 5 quarters since.
  • Legal & General Group's Beta Bionics position peaked at $199K in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.